Joann M. Zamparo

2.0k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

Joann M. Zamparo is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Joann M. Zamparo has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 7 papers in Health and 7 papers in Epidemiology. Recurrent topics in Joann M. Zamparo's work include SARS-CoV-2 and COVID-19 Research (11 papers), Vaccine Coverage and Hesitancy (7 papers) and COVID-19 Clinical Research Studies (6 papers). Joann M. Zamparo is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), Vaccine Coverage and Hesitancy (7 papers) and COVID-19 Clinical Research Studies (6 papers). Joann M. Zamparo collaborates with scholars based in United States. Joann M. Zamparo's co-authors include John M. McLaughlin, Luis Jódar, Timothy B. Frankland, Vennis Hong, Sara Y. Tartof, Bradley K. Ackerson, Jeff Slezak, Oluwaseye Ayoola Ogun, Srinivas Rao Valluri and Sharon Gray and has published in prestigious journals such as The Lancet, Journal of Virology and Emerging infectious diseases.

In The Last Decade

Joann M. Zamparo

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

2021 727 citations Sara Y. Tartof, Jeff Slezak et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joann M. Zamparo United States	11	897	421	238	135	103	20	1.1k
Amy Flaxman United Kingdom	9	783 0.9×	280 0.7×	86 0.4×	116 0.9×	71 0.7×	17	998
Pedro M. Folegatti United Kingdom	9	834 0.9×	295 0.7×	87 0.4×	176 1.3×	81 0.8×	13	1.1k
Thomas A. Rawlinson United Kingdom	6	712 0.8×	278 0.7×	81 0.3×	76 0.6×	67 0.7×	8	958
Natalie G. Marchevsky United Kingdom	5	721 0.8×	278 0.7×	81 0.3×	70 0.5×	70 0.7×	16	877
Carla Talarico United States	12	585 0.7×	221 0.5×	84 0.4×	209 1.5×	67 0.7×	27	772
Valentina Marziano Italy	15	436 0.5×	164 0.4×	483 2.0×	210 1.6×	30 0.3×	36	903
Philip Meade United States	11	1.2k 1.3×	74 0.2×	151 0.6×	373 2.8×	117 1.1×	23	1.5k
Jennifer H Ku United States	17	603 0.7×	235 0.6×	88 0.4×	310 2.3×	57 0.6×	54	1.0k
Qunying Mao China	11	500 0.6×	124 0.3×	78 0.3×	49 0.4×	77 0.7×	23	659
Angkana T. Huang United States	10	817 0.9×	56 0.1×	191 0.8×	83 0.6×	43 0.4×	22	986

Countries citing papers authored by Joann M. Zamparo

Since Specialization

Citations

This map shows the geographic impact of Joann M. Zamparo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joann M. Zamparo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joann M. Zamparo more than expected).

Fields of papers citing papers by Joann M. Zamparo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joann M. Zamparo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joann M. Zamparo. The network helps show where Joann M. Zamparo may publish in the future.

Co-authorship network of co-authors of Joann M. Zamparo

This figure shows the co-authorship network connecting the top 25 collaborators of Joann M. Zamparo. A scholar is included among the top collaborators of Joann M. Zamparo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joann M. Zamparo. Joann M. Zamparo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Penrose, Kate, McKaylee Robertson, Kristen E. Allen, et al.. (2025). Changes in intentions, behavior, and reasons to receive COVID-19 vaccination December 2020–August 2023. Vaccine X. 25. 100689–100689.

Tartof, Sara Y., Mark A. Schmidt, Richard Contreras, et al.. (2024). Burden of Medically Attended Diarrhea and OutpatientClostridioides difficileInfection Among Persons in 2 Large Integrated Healthcare Settings, 2016–2021. Open Forum Infectious Diseases. 11(1). ofad680–ofad680. 1 indexed citations

Tartof, Sara Y., Timothy B. Frankland, Laura Puzniak, et al.. (2024). BNT162b2 XBB Vaccine for COVID-19 Among Children 5-17 Years of Age. JAMA Network Open. 7(12). e2449944–e2449944. 2 indexed citations

Ramírez, Julio A., Frederick J. Angulo, Ruth Carrico, et al.. (2023). Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019–20201. Emerging infectious diseases. 29(5). 919–928. 3 indexed citations

Tartof, Sara Y., Jeff Slezak, Laura Puzniak, et al.. (2023). Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System. JAMA Network Open. 6(1). e2251833–e2251833. 18 indexed citations

Fusco, Manuela Di, Xiaowu Sun, Mary M. Moran, et al.. (2023). Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron. Journal of Patient-Reported Outcomes. 7(1). 77–77. 20 indexed citations

Tartof, Sara Y., Jeff Slezak, Laura Puzniak, et al.. (2023). Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case–control study. The Lancet Respiratory Medicine. 11(12). 1089–1100. 33 indexed citations

Shen, Yanhan, McKaylee Robertson, Sarah Kulkarni, et al.. (2023). Oral COVID-19 Antiviral Uptake Among a Highly Vaccinated US Cohort of Adults With SARS-CoV-2 Infection Between December 2021 and October 2022. Open Forum Infectious Diseases. 11(2). ofad674–ofad674. 2 indexed citations

Sun, Xiaowu, Manuela Di Fusco, Laura Puzniak, et al.. (2023). Assessment of retrospective collection of EQ-5D-5L in a US COVID-19 population. Health and Quality of Life Outcomes. 21(1). 103–103. 10 indexed citations

10.

Tartof, Sara Y., Timothy B. Frankland, Laura Puzniak, et al.. (2023). BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5–11 Years of Age: A Test Negative Design. Journal of the Pediatric Infectious Diseases Society. 12(3). 177–179. 3 indexed citations

11.

Fridkin, Scott K., Chad Robichaux, Jessica Traenkner, et al.. (2022). Determinates of Clostridioides difficile infection (CDI) testing practices among inpatients with diarrhea at selected acute-care hospitals in Rochester, New York, and Atlanta, Georgia, 2020–2021. Infection Control and Hospital Epidemiology. 44(7). 1085–1092. 5 indexed citations

12.

Khan, Farid, Jennifer L. Nguyen, Tanya Singh, et al.. (2022). Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age. JAMA Network Open. 5(12). e2246915–e2246915. 21 indexed citations

13.

Tartof, Sara Y., Jeff Slezak, Laura Puzniak, et al.. (2022). Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study. The Lancet Regional Health - Americas. 9. 100198–100198. 80 indexed citations

14.

Angulo, Frederick J., Ruth Carrico, Stephen Furmanek, et al.. (2022). Frequency of stool specimen collection and testing for Clostridioides difficile of hospitalized adults and long-term care facility residents with new-onset diarrhea in Louisville, Kentucky. International Journal of Infectious Diseases. 120. 196–200. 3 indexed citations

15.

Fusco, Manuela Di, Xiaowu Sun, Mary M. Moran, et al.. (2022). Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients. Journal of Patient-Reported Outcomes. 6(1). 123–123. 24 indexed citations

16.

Tartof, Sara Y., Jeff Slezak, Heidi Fischer, et al.. (2021). Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. The Lancet. 398(10309). 1407–1416. 727 indexed citations breakdown →

17.

Tartof, Sara Y., Jeff Slezak, Heidi Fischer, et al.. (2021). Six-Month Effectiveness of BNT162B2 mRNA COVID-19 Vaccine in a Large US Integrated Health System: A Retrospective Cohort Study. SSRN Electronic Journal. 16 indexed citations

18.

Tartof, Sara Y., Jeff Slezak, Laura Puzniak, et al.. (2021). Effectiveness of a Third Dose of BNT162b2 mRNA COVID-19 Vaccine in a Large US Health System: A Retrospective Cohort Study. SSRN Electronic Journal. 29 indexed citations

19.

Zamparo, Joann M., et al.. (2001). Rearrangement of the Genes of Vesicular Stomatitis Virus Eliminates Clinical Disease in the Natural Host: New Strategy for Vaccine Development. Journal of Virology. 75(13). 6107–6114. 78 indexed citations

20.

Zamparo, Joann M., et al.. (1997). Serologic Evidence of Jamestown Canyon Virus Infection in White-Tailed Deer Populations from Connecticut. Journal of Wildlife Diseases. 33(3). 623–627. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact